Developing a new gel and membrane system for better protein analysis
Gelbrane: Combined Gel and Membrane for Robust Western Blotting
['FUNDING_OTHER'] · BLOTTING INNOVATIONS, LLC · NIH-10759072
This study is working on a new product that makes it easier and more reliable for scientists to find specific proteins in samples, which can help improve research that benefits patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BLOTTING INNOVATIONS, LLC (nih funded) |
| Locations | 1 site (CENTRAL, UNITED STATES) |
| Trial ID | NIH-10759072 on ClinicalTrials.gov |
What this research studies
This research aims to create a novel gel and membrane system called gelbrane, which simplifies the process of Western blotting, a common technique used to detect specific proteins in biological samples. By combining a precast polyacrylamide gel with a transfer membrane, the gelbrane reduces the risk of errors that can occur during the manual assembly of transfer components. This innovation seeks to enhance the reliability and reproducibility of protein analysis, which is crucial for various biomedical applications. Patients may benefit indirectly from improved research outcomes that rely on accurate protein detection.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals involved in biomedical research or those with conditions requiring precise protein analysis.
Not a fit: Patients who are not involved in biomedical research or do not require protein analysis may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more reliable and efficient protein analysis methods, ultimately improving biomedical research and patient care.
How similar studies have performed: While Western blotting is a well-established technique, the approach of combining gel and membrane in this manner is novel and has not been widely tested.
Where this research is happening
CENTRAL, UNITED STATES
- BLOTTING INNOVATIONS, LLC — CENTRAL, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BIRTWISTLE, MARC R. — BLOTTING INNOVATIONS, LLC
- Study coordinator: BIRTWISTLE, MARC R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.